Semaglutide Slows Aging, Aids Health

This is a news story, published by Guardian, that relates primarily to Wegovy and Ozempic news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Guardian news

For more news from Guardian, you can click here:

more news from Guardian

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

loss drugs

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest semaglutide news, cardiovascular disease news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

adverse cardiovascular outcomes

Guardian

•

Weight-loss drugs ‘slow down the ageing process’, scientists find

Summary

Nutrition label

82% Informative

People who took the drug died at a lower rate from all causes, not just from cardiovascular causes, researchers discovered.

Semaglutide also known by the brand names Wegovy and Ozempic reduced the risk of death in people who were obese or overweight and had cardiovascular disease.

Fresh studies have found that the drug has impacts beyond what was originally imagined for the drug.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech